BDX (Becton Dickinson) Common Stock: $371 Mil (As of Mar. 2026)


BDX Becton Dickinson & Co BDX
76 GF Score
Price $151.38
GF Value $191.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Common Stock?

Becton Dickinson BDX +2.44% 76 Common Stock is $371 Mil as of Mar. 2026. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Becton Dickinson's quarterly common stock stayed the same from Sep. 2025 ($371 Mil) to Dec. 2025 ($371 Mil) and stayed the same from Dec. 2025 ($371 Mil) to Mar. 2026 ($371 Mil).

Becton Dickinson's annual common stock stayed the same from Sep. 2023 ($371 Mil) to Sep. 2024 ($371 Mil) and stayed the same from Sep. 2024 ($371 Mil) to Sep. 2025 ($371 Mil).

Becton Dickinson Common Stock Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Common Stock Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 365.00 365.00 371.00 371.00 371.00

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 371.00 371.00 371.00 371.00 371.00
BDX
76GF Score
Becton Dickinson & Co BDX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $371 Mil mean?
Becton Dickinson (BDX) has a Common Stock of $371 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Common Stock too high?
Becton Dickinson's current Common Stock is $371 Mil. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Common Stock compare to MDLN and RMD?
Becton Dickinson's Common Stock of $371 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Common Stock is $371 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current Common Stock is $371 Mil. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Becton Dickinson (BDX), the current Common Stock is $371 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for BDX:

  • Common Stock: $371 Mil
  • GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for BDX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$151.38
Price
$191.05
GF Value